NL193308B - Doseervorm geschikt voor de afgifte van een preparaat van een heilzaam middel aan een gebruiksomgeving. - Google Patents

Doseervorm geschikt voor de afgifte van een preparaat van een heilzaam middel aan een gebruiksomgeving.

Info

Publication number
NL193308B
NL193308B NL8701102A NL8701102A NL193308B NL 193308 B NL193308 B NL 193308B NL 8701102 A NL8701102 A NL 8701102A NL 8701102 A NL8701102 A NL 8701102A NL 193308 B NL193308 B NL 193308B
Authority
NL
Netherlands
Prior art keywords
delivering
environment
dosage form
form suitable
beneficial agent
Prior art date
Application number
NL8701102A
Other languages
English (en)
Other versions
NL8701102A (nl
NL193308C (nl
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NL8701102A publication Critical patent/NL8701102A/nl
Publication of NL193308B publication Critical patent/NL193308B/nl
Application granted granted Critical
Publication of NL193308C publication Critical patent/NL193308C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8701102A 1986-05-09 1987-05-08 Doseervorm geschikt voor de afgifte van een preparaat van een heilzaam middel aan een gebruiksomgeving. NL193308C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86118886 1986-05-09
US06/861,188 US4842867A (en) 1986-05-09 1986-05-09 Pulsed drug delivery of doxylamine

Publications (3)

Publication Number Publication Date
NL8701102A NL8701102A (nl) 1987-12-01
NL193308B true NL193308B (nl) 1999-02-01
NL193308C NL193308C (nl) 1999-06-02

Family

ID=25335124

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701102A NL193308C (nl) 1986-05-09 1987-05-08 Doseervorm geschikt voor de afgifte van een preparaat van een heilzaam middel aan een gebruiksomgeving.

Country Status (14)

Country Link
US (1) US4842867A (nl)
JP (2) JPS62298529A (nl)
KR (1) KR950010144B1 (nl)
AU (1) AU621030B2 (nl)
BE (1) BE1000232A5 (nl)
CA (1) CA1297368C (nl)
CH (1) CH671696A5 (nl)
DE (1) DE3715224C2 (nl)
ES (1) ES2005571A6 (nl)
FR (1) FR2598319B1 (nl)
IT (1) IT1208883B (nl)
NL (1) NL193308C (nl)
SE (1) SE502684C2 (nl)
ZA (1) ZA873091B (nl)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141752A (en) * 1986-05-09 1992-08-25 Alza Corporation Delayed drug delivery device
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5252338A (en) * 1991-06-27 1993-10-12 Alza Corporation Therapy delayed
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5190765A (en) * 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
US5308348A (en) * 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
US5209746A (en) * 1992-02-18 1993-05-11 Alza Corporation Osmotically driven delivery devices with pulsatile effect
US5456679A (en) * 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5221278A (en) * 1992-03-12 1993-06-22 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
ZA935569B (en) * 1992-07-31 1994-04-12 Daratech Pty Ltd Controlled release implants
US5391378A (en) * 1993-02-22 1995-02-21 Elizabeth-Hata International, Inc. Two-part medicinal tablet and method of manufacture
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5718700A (en) * 1994-09-20 1998-02-17 Alza Corporation Exit means in dosage form
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
ATE234602T1 (de) * 1996-08-16 2003-04-15 Alza Corp Verabreichungsform zur abgabe von steigenden wirkstoffdosen
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
AU9062998A (en) * 1997-09-11 1999-03-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
US6372254B1 (en) * 1998-04-02 2002-04-16 Impax Pharmaceuticals Inc. Press coated, pulsatile drug delivery system suitable for oral administration
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
CA2341297C (en) * 1998-09-09 2009-02-24 Alza Corporation Dosage form comprising liquid formulation
RU2246295C2 (ru) * 1998-11-02 2005-02-20 Элзэ Копэрейшн Лекарственная форма c постоянной скоростью высвобождения лекарственного вещества, ядро лекарственной формы и способ обеспечения облегченного высвобождения лекарственного вещества из лекарственной формы
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
CA2440641A1 (en) * 2001-03-13 2002-09-19 Anand R. Baichwal Chronotherapeutic dosage forms containing glucocorticosteroid
EP1492509A1 (en) * 2001-12-18 2005-01-05 ALZA Corporation Dosage form providing time-varying patterns of drug delivery
CN1606434A (zh) * 2001-12-19 2005-04-13 株式会社三和化学研究所 控制释放成型品
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20070078513A1 (en) * 2002-09-18 2007-04-05 Medtronic Vascular, Inc. Controllable drug releasing gradient coatings for medical devices
EP1556017A1 (en) * 2002-10-31 2005-07-27 ALZA Corporation Dosage form providing ascending release of liquid formulation
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
NZ545921A (en) * 2003-09-19 2009-09-25 Penwest Pharmaceuticals Co Delayed released dosage forms
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
NZ599524A (en) 2009-11-09 2014-04-30 Spotlight Technology Partners Llc Polysaccharide based hydrogels
WO2011057133A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Fragmented hydrogels
CA2848798C (en) 2012-02-22 2014-12-23 Duchesnay Inc. Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
WO2013123569A1 (en) * 2012-02-22 2013-08-29 Duchesnay Inc. Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
JP6379194B2 (ja) 2013-07-22 2018-08-22 デュシネイ・インコーポレイテッド 悪心及び嘔吐の管理のための組成物
US9452181B2 (en) 2013-07-22 2016-09-27 Duchesnay Inc. Composition for the management of nausea and vomiting
TWI595874B (zh) 2014-08-29 2017-08-21 達契斯奈股份有限公司 多西拉敏及吡哆醇及／或其代謝產物或鹽之多模式釋放調配物
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4298003A (en) * 1980-05-12 1981-11-03 Alza Corporation System for delivering agent at zero order rate with emerging agent below saturation
US4439196A (en) * 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom

Also Published As

Publication number Publication date
CA1297368C (en) 1992-03-17
KR950010144B1 (ko) 1995-09-11
IT8767393A0 (it) 1987-05-07
BE1000232A5 (fr) 1988-09-20
FR2598319A1 (fr) 1987-11-13
DE3715224A1 (de) 1987-11-12
ES2005571A6 (es) 1989-03-16
JPH07116018B2 (ja) 1995-12-13
NL8701102A (nl) 1987-12-01
IT1208883B (it) 1989-07-10
JPS62267221A (ja) 1987-11-19
FR2598319B1 (fr) 1989-12-01
ZA873091B (en) 1987-12-30
CH671696A5 (nl) 1989-09-29
KR870010866A (ko) 1987-12-18
AU7183787A (en) 1987-11-12
NL193308C (nl) 1999-06-02
DE3715224C2 (de) 1997-02-20
AU621030B2 (en) 1992-03-05
US4842867A (en) 1989-06-27
JPS62298529A (ja) 1987-12-25
SE8701900D0 (sv) 1987-05-08
SE8701900L (sv) 1987-11-10
SE502684C2 (sv) 1995-12-11

Similar Documents

Publication Publication Date Title
NL193308B (nl) Doseervorm geschikt voor de afgifte van een preparaat van een heilzaam middel aan een gebruiksomgeving.
NL194719B (nl) Gevormd oraal preparaat voor de geregelde toediening van een nuttig middel aan herkauwers.
NL184094C (nl) Voortbrengsel voor de vertraagde afgifte van een geneesmiddel aan herkauwers.
NO176466C (no) Fremgangsmåte til fremstilling av doseringsenhet for avgivelse av et aktivt middel til et bruksmiljö
NL194956B (nl) Preparaat voor de afgifte van een heilzaam middel.
DE2861289D1 (en) Imidazolidine derivatives, process for their preparation, intermediates for use in this process, pharmaceutical compositions containing them and the use of the active compounds
PT77488A (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
NL930039I1 (nl) Derivaten van cis endo-2-azabicyclo-(3,3,0)-octaan-3-carbonzuur werkwijze voor de bereiding daarvan deze stoffen bevattende middelen en hun toepassing
NL182372C (nl) Inhalatieinrichting voor het aan een patient toedienen van een poedervormig medicament.
NL186576C (nl) Werkwijze voor het bereiden van een chemisch-gemodificeerd hyaluronzuurpreparaat en chemisch-gemodificeerd hyaluronzuurpreparaat.
NL192793B (nl) Deoxyuridinederivaten met antivirale werking; werkwijze voor de bereiding daarvan en geneesmiddel tegen virusziekten.
NL990002I1 (nl) Rechtsdraaiend enenantiomeer van alfa (4,5,6,7-tetrahydrothienoÄ3,2-cÄ007fÜ-pyrid-5-yl)(2-chloorfenyl) methylacetaat, werkwijze voor de bereiding daarvan en deze bevattende farmaceutische preparaten.
NL7701849A (nl) Werkwijze voor de bereiding van geneesmiddelen onder toepassing van pyrethrinoiden.
NL185446C (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat te gebruiken als inhalatie-aerosol.
BE870531A (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
ATE4707T1 (de) Pyridyl- und imidazopyridyloxypropanolamine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen sie enthaltend.
IT7950977A0 (it) Composti farmaceutici ad azione antiulcera e procedimento per la loro preparazione
NL7809664A (nl) Werkwijze voor de bereiding van een huidontsmettings- zalf.
FR2485537B2 (fr) Dipyrido(4,3-b)(3,4-f)indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
NL7801857A (nl) Porienhoudend vormlichaam uit geregenereerde cellulose voor gebruik in de geneeskunde.
IT7950138A0 (it) Composizione farmaceutica per il trattamento dei parkinsonismi
DE3066483D1 (en) Pharmaceutical compositions based on secretin with enhanced and protracted activity, process for their preparation and dihydroxybenzoyl-l-tyrosine
DE2961053D1 (en) Norbornene(-ane) derivatives, process for their preparation and their use as perfuming agents
IT8468196A1 (it) Dispositivo osmotico e procedimento per l'erogazione di un agente benefico, particolarmente di un farmaco ad un ambiente d'uso.
AR219370A1 (es) Procedimiento de preparacion de composiciones farmaceuticas detoxificadas de agentes alquilantes citostaticamente activos

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20070508